Monthly Archives: January 2012
Internet Addiction Linked to Childhood Depression
According to research printed in the Journal Pediatrics, children who have an unhealthy addiction to the internet are almost twice as likely to suffer from depression. That is an alarming number, and parents should be concerned. The study tracked 1,041 teens in China, where internet addiction is a serious problem. The teens were asked a series of questions in order to assess their risk of depression. Out of the teens studied, 94% were considered unhealthy internet users, and the other 6% were found to be moderately unhealthy internet users.
The researchers evaluated the teens’ risk of depression again 9 months later, and found that the teens with unhealthy internet addiction were one and a half times more likely to show symptoms of depression. While this may seem alarming, teen depression is not new. It’s estimated that over 2 million teens and pre-teens develop depression every year. However, the problem has become so prevalent that a government panel has advised doctors to screen children aged from 12-18 for depression routinely.
Parents should take note and watch for signs of depression, which can include:
Difficulty concentrating and making decisionsLoss of interest in activities that were once enjoyableLoss of energyFeelings of hopelessness or lack of self-worthInsomnia or excessive sleepingOvereating or loss of appetiteThoughts or attempts of suicide
If you or someone you know is suffering from these symptoms, seek professional help immediately.
MindSoothe Jr.
View the Original article
Women Combating Depression With Coffee
A cup of coffee in the morning is routine for many- just the smell of it can help wake you up. It’s what gets us through the day; most would have a difficult work day without coffee.
A new study conducted by Harvard University gives many women another reason to drink coffee. The study published in the Archives of Internal Medicine found that women who consumed 2-3 cups of coffee a day had a 15% lower risk of depression, and those who drank more had a 20% lower risk.
Over the past 10 year’s doctors, monitored the women’s caffeine intake and noted which participants developed signs of depression during this timeframe. The study consisted of over 50,000 women and was one of the largest women’s studies in America. The average age of the patients was 60 and none were previously diagnosed with depression.
While this may seem like amazing news, the authors caution that more work must be done and they are in the early stages of research. The data must be replicated before any conclusive information can be drawn. At best, this study gives coffee drinkers a piece of mind.
Melancholy Lift
View the Original article
Depression sometimes shifts to bipolar disorder
David Mrazek, M.D.
Dr. David A. Mrazek is chair of the Department of Psychiatry and Psychology at Mayo Clinic, Rochester, Minn., and a professor of psychiatry at College of Medicine, Mayo Clinic. Dr. Mrazek has developed a federally funded psychiatric pharmacogenomics research program and implemented clinical psychiatric pharmacogenomics services at Mayo Clinic.
He has received numerous awards including the Award for Creativity in Psychiatric Education from the American College of Psychiatrists and the Agnes Purcell McGavin Award for Distinguished Career Achievement in Child and Adolescent Psychiatry from the American Psychiatric Association. He currently serves as chairman of the board of the American Board of Psychiatry and Neurology.
Dr. Mrazek has focused his current efforts on using pharmacogenomics testing to improve clinical care. One of his specific goals is to decrease the risks of taking psychiatric medications.
Latest entries
Jan. 21, 2012
Antidepressant use soaring among Americans 12 and over
Dec. 7, 2011
Transcranial magnetic stimulation offers hope treating depression
Oct. 19, 2011
New antidepressant offers hope
Sept. 3, 2011
Sorting out the evidence for antidepressants
July 22, 2011
Connect with others who’ve been there.Share stories. Learn. Join Mayo Clinic’s
online community. Free E-Newsletters
Subscribe to receive the latest updates on health topics. About our newsletters
HousecallAlzheimer’s caregiving Living with cancer
View the Original article
Transcranial magnetic stimulation offers hope treating depression
David Mrazek, M.D.
Dr. David A. Mrazek is chair of the Department of Psychiatry and Psychology at Mayo Clinic, Rochester, Minn., and a professor of psychiatry at College of Medicine, Mayo Clinic. Dr. Mrazek has developed a federally funded psychiatric pharmacogenomics research program and implemented clinical psychiatric pharmacogenomics services at Mayo Clinic.
He has received numerous awards including the Award for Creativity in Psychiatric Education from the American College of Psychiatrists and the Agnes Purcell McGavin Award for Distinguished Career Achievement in Child and Adolescent Psychiatry from the American Psychiatric Association. He currently serves as chairman of the board of the American Board of Psychiatry and Neurology.
Dr. Mrazek has focused his current efforts on using pharmacogenomics testing to improve clinical care. One of his specific goals is to decrease the risks of taking psychiatric medications.
Latest entries
Oct. 19, 2011
New antidepressant offers hope
Sept. 3, 2011
Sorting out the evidence for antidepressants
July 22, 2011
Perseverance can pay off in finding right antidepressant
June 17, 2011
Why do antidepressants stop working?
May 6, 2011
Connect with others who’ve been there.Share stories. Learn. Join Mayo Clinic’s
online community. Free E-Newsletters
Subscribe to receive the latest updates on health topics. About our newsletters
HousecallAlzheimer’s caregiving Living with cancer
View the Original article
Transcranial magnetic stimulation can treat depression
David Mrazek, M.D.
Dr. David A. Mrazek is chair of the Department of Psychiatry and Psychology at Mayo Clinic, Rochester, Minn., and a professor of psychiatry at College of Medicine, Mayo Clinic. Dr. Mrazek has developed a federally funded psychiatric pharmacogenomics research program and implemented clinical psychiatric pharmacogenomics services at Mayo Clinic.
He has received numerous awards including the Award for Creativity in Psychiatric Education from the American College of Psychiatrists and the Agnes Purcell McGavin Award for Distinguished Career Achievement in Child and Adolescent Psychiatry from the American Psychiatric Association. He currently serves as chairman of the board of the American Board of Psychiatry and Neurology.
Dr. Mrazek has focused his current efforts on using pharmacogenomics testing to improve clinical care. One of his specific goals is to decrease the risks of taking psychiatric medications.
Latest entries Transcranial magnetic stimulation offers hope treating depression
Oct. 19, 2011
New antidepressant offers hope
Sept. 3, 2011
Sorting out the evidence for antidepressants
July 22, 2011
Perseverance can pay off in finding right antidepressant
June 17, 2011
Why do antidepressants stop working?
May 6, 2011
Connect with others who’ve been there.Share stories. Learn. Join Mayo Clinic’s
online community. Free E-Newsletters
Subscribe to receive the latest updates on health topics. About our newsletters
HousecallAlzheimer’s caregiving Living with cancer
View the Original article
